Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2017 / Cilt: 51 - Sayı: 4

Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia

Erken başlangıçlı androgenetik alopeside iskemi modifiye albümin düzeyi ve oksidatif stres ile ilişkili parametrelerin değerlendirilmesi

Pages
115–118
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On the other hand, there was no significant correlation between AGA and IMA

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Ischemia-modified albumin (IMA) is a biomarker, which is an indicator of ischemia and oxidative stress, and measured by the albumin cobalt binding test.
📊
Key Findings & Data:The aim of the present study was to investigate the factors affecting AGA, and the correlation between AGA and IMA.Materials and Methods: Fifty male patients with AGA aged 18-35 years and 30 males of similar age without AGA were included in the study.
💡
Conclusion & Impact:On the other hand, there was no significant correlation between AGA and IMA
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Background and Design: Ischemia-modified albumin (IMA) is a biomarker, which is an indicator of ischemia and oxidative stress, and measured by the albumin cobalt binding test. Androgenetic alopecia (AGA) is the most important cause of hair loss in males. Hair loss that is affected by androgenic hormones, age, and ethnic, family and environmental factors, may lead to psychological, social and physical problems in some individuals. The aim of the present study was to investigate the factors affecting AGA, and the correlation between AGA and IMA.Materials and Methods: Fifty male patients with AGA aged 18-35 years and 30 males of similar age without AGA were included in the study. Patients with AGA stage 3 or higher were included in the study group. Blood samples were collected after a 12-hour fasting period. Blood glucose, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride, insulin, testosterone, dehydroepiandrosterone-sulfate (DHEA-S), and albumin levels were analyzed using an autoanalyzer. IMA values were evaluated using a MINDRAY BS 2000 autoanalyzer.Results: A total of 80 individuals were included in the study. There was no significant difference in mean age (p=0.179), body mass index (p=0.847), DHEA-S (p=0.247), testosterone (p=0.874), lipid profile [triglyceride (p=0.086), total cholesterol (p=0.492), HDL (p=0.993), LDL (p=0.544)], insulin resistance (p=0.399) and IMA (p=0.976) between study group and control group. Additionally, a family history of alopecia was found to be significantly higher in the study group (p=0.000). Moreover, there was a positive correlation between AGA grade and insulin resistance (r=0.296; p=0.037).Conclusion: AGA, which leads to many cosmetic and psychosocial problems, was more frequent in individuals with a family history of alopecia; also, there was a positive correlation between AGA stage and insulin resistance. On the other hand, there was no significant correlation between AGA and IMA

Özet

Amaç: İskemi modifiye albümin (İMA), albümin kobalt bağlama testi ile ölçülen, iskemi ve oksidatif stresin göstergesi olan bir biyomarkırdır. Androgenetik alopesi (AGA) erkeklerde görülen saç kaybının en önemli nedenidir. Androjenik hormonlar, yaş, etnik, ailesel ve çevresel faktörlerden etkilenen saç kaybı bireylerde ruhsal, sosyal ve fiziksel yetersizliklere yol açabilmektedir. Bu çalışmada AGA'yı etkileyen faktörler ve çeşitli alanlarda kullanılan önemli bir belirteç olan İMA ile AGA arasındaki ilişkinin ortaya konması amaçlanmıştır.Gereç ve Yöntem: Çalışmaya AGA'sı olan 50 erkek olgu ile (18-35 yaş arasındaki) AGA'sı olmayan 30 erkek olgu (aynı yaş aralığında) alındı. Evre 3 ve üzerinde olanlar çalışma grubuna dahil edildi. Kan örnekleri 12 saat açlık sonrası alındı. Kan glukoz, total kolesterol, yüksek dansiteli lipoprotein (HDL), düşük dansiteli lipoprotein (LDL), trigliserid, insülin, testosteron ve dehidroepiandesteron-sülfat (DHEA-S) ve albümin değerleri otoanalizörde bakıldı. İMA örnekleri MINDRAY BS 2000 otoanalizörüne aplike edilerek çalışıldı.Bulgular: Çalışmaya 50 AGA'lı 30 kontrol toplam 80 olgu alındı. Çalışma grubu ile kontrol grubu yaş ortalaması (p=0,179), vücut kitle indeksi (p=0,847), DHEA-S (p=0,247), testosteron (p=0,874), lipit profili [trigliserid (p=0,086), total kolesterol (p=0,492), HDL (p=0,993), LDL (p=0,544)], insülin direnci (p=0,399) ve İMA (p=0,976) açısından değerlendirildiğinde iki grup arasında istatistiksel olarak anlamlı fark yoktu. Buna karşın ailede kellik öyküsü çalışma grubunda istatistiksel olarak anlamlı derecede fazlaydı (p=0,000) ve AGA derecesi ile insülin direnci arasında pozitif yönde bir korelasyon vardı (r=0,296; p=0,037).Sonuç: Kozmetik ve psikososyal birçok soruna neden olan AGA'nın; ailesinde kellik öyküsü olanlarda daha sık gözlendiği ve AGA derecesi ile insülin direnci arasında pozitif yönde bir korelasyon olduğu saptandı. AGA ile İMA arasında ise anlamlı bir ilişki olmadığı belirlendi

🔖

Cite This Article

NAZİK, H., DEMİR, B., NAZİK, S., GÜL, F. Ç., KİRAZ, Z. K. (2022). Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 51 - Sayı: 4, 115–118. https://ajindex.com/articles/621715

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bar-Or D, Lau E, Winkler JV: A novel assay for cobalt-abumin binding and its potential as a marker for myocardial ischemia a preliminary report. J Emerg Med 2000;19:311-5
  2. Bhagavan NV, Lai EM, Rios PA, et al: Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5
  3. Piva SJ, Duarte MM, Da Cruz IB, et al: Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clin Biochem 2011;44:345-7
  4. Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S: Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertil Steril 2011;95:310-3
  5. Duarte MM, Rocha JB, Moresco RN, et al: Association between ischemiamodified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71
  6. Hanneken S, Ritzmann S, Nöthen MM, Kruse R: Androgenetic alopecia: current aspects of a common phenotype. Hautarzt 2003;54:703-12
  7. Cash TF: The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 1999;141:398-405
  8. Otberg N, Finner A, Shapiro J: Androgenetic alopecia. Endocrinol Metab Clin North Am 2007;36:379-98
  9. Gonçalves Mota MP, Santos Z, Soares J, et al: Oxidative Stress Function in Women over 40 Years of Age, Considering Their Lifestyle. Front Endocrinol (Lausanne) 2017;8:48
  10. Hamilton JB: Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951;53:708-28
  11. Severi G, Sinclair R, Hopper JL, et al: Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003;149:1207-13
  12. Kaufman KD: Androgenes and alopecia. Mol Cell Endocrinol 2002;198:89- 95
  13. Narad S, Pande S, Gupta M, Chari S: Hormonal profile in Indian men with premature androgenetic alopecia. Int J Trichology 2013;5:69-72
  14. Starka L, Hill M, Polacek V: Hormonal profile in men with premature androgenic alopecia. Sb Lek 2000;101:17-22
  15. Tsvetanova A, Gospodinov D, Donchev M: Serum-concentrations of dehydroepyandrosterone- sulfate in men with androgenetic alopecia. Int Med Assoc Bulg 2004;10:38-41
  16. Sharma L, Dubey A, Gupta PR, Agrawal A: Androgenetic alopecia and risk of coronary artery disease. Indian Dermatol Online J 2013;4:283-7
  17. Chakrabarty S, Hariharan R, Gowda D, Suresh H: Association of prematüre androgenetic alopecia and metabolic syndrome in a young Indian populati